Melmed, G., Botwin, G. J., Younis, Z., Wolf, D. C., Chiorean, M., Cohen, E. R., Boland, B., Flynn, A. D., Fudman, D., Hou, J., Lazarev, M., Lum, D. F., Mattar, M. C., McConnell, R., Ostrov, A., Parekh, N., Raffals, L., Sheibani, S., Siegel, C., Valentine, J., Morganstern, B., Horizon, A., Venuturupalli, S., Wallace, D. J., Glover, S., Ehrlich, A. C., Ha, C., Syal, G., Kumar, R., Appel, K. L., Mujukian, A., Rabizadeh, S., Feldman, E. J., Stein, T., Cheng, S., Ebinger, J., Sobhani, K., Braun, J., & McGovern, D. (n.d.). s926 Effects of Immune Modifying Therapies on Antibody Responses Following SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease. American journal of gastroenterology, 116, S438–S439. http://access.bl.uk/ark:/81055/vdc_100144523715.0x00001b